tiprankstipranks
Eledon Pharmaceuticals Announces $85 Million Stock Offering
Company Announcements

Eledon Pharmaceuticals Announces $85 Million Stock Offering

Don't Miss our Black Friday Offers:

Eledon Pharmaceuticals ( (ELDN) ) has shared an update.

Eledon Pharmaceuticals announced an $85 million underwritten offering of common stock and pre-funded warrants, with the proceeds intended to advance its pipeline and general corporate purposes. The offering, priced at $3.65 per share for common stock and $3.649 for pre-funded warrants, is expected to close by October 30, 2024, subject to customary conditions. This initiative aims to further Eledon’s development of immune-modulating therapies, including its lead product, tegoprubart, targeting life-threatening conditions.

See more insights into ELDN stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyEledon Pharmaceuticals price target lowered to $20.50 from $28 at Ladenburg
TipRanks Auto-Generated NewsdeskEledon Pharmaceuticals Reports Strong Q3 2024 Results
TheFlyEledon Pharmaceuticals reports Q3 EPS (32c), consensus (31c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App